Quell Therapeutics
Cell therapy for immunology
- B2B
About Quell Therapeutics
A dynamic biotech company dedicated to advancing cell therapy for solid organ transplantation and auto-immune conditions, with a focus on patient-centric innovation and collaboration
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- London, United Kingdom
- Founded
- 2019
- Revenue
- $13M – $103MTamtam estimate
- Website
- quell-tx.com
Quell Therapeutics at a glance
Quell Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in London, United Kingdom.
Quell Therapeutics was founded in 2019.
Quell Therapeutics has 51–250 employees.
Quell Therapeutics's revenue is $13M – $103M (Tamtam estimate).
Selling to companies like Quell Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies